美国三大药品分销商麦克森,卡迪纳尔健康和Cencora在联邦法院以3亿美元的价格解决了阿片类药物流行病的诉讼. 3 major US drug distributors, McKesson, Cardinal Health, and Cencora, settle opioid epidemic claims for $300m in federal court.
美国三大药品分销商麦克森,卡迪纳尔健康和Cencora (前身为AmerisourceBergen) 已同意支付3亿美元,以解决医疗保险公司的索赔和福利计划,他们为美国阿片类药物流行做出了贡献. 3 major US drug distributors, McKesson, Cardinal Health, and Cencora (previously AmerisourceBergen), have agreed to pay $300m to resolve claims by health insurers and benefit plans that they contributed to the US opioid epidemic. 作为追究制药商、分销商和药房对毒瘾危机负责的数千起诉讼的一部分，这项和解是主要与各州和地方政府达成的超过 500 亿美元的和解的一部分。 As part of thousands of lawsuits filed to hold drugmakers, distributors, and pharmacies liable for the drug addiction crisis, this settlement is part of over $50bn in settlements reached primarily with states and local governments. 拟议的集体诉讼和解协议已提交给俄亥俄州克利夫兰的联邦法院，需要法官的批准，McKesson 将支付 38.1%、Cardinal 30.9% 和 Cencora 31%。 The proposed class action settlement, filed in federal court in Cleveland, Ohio, requires a judge's approval and will see McKesson pay 38.1%, Cardinal 30.9%, and Cencora 31%.